Targadox Tablet
Product Images NDC 69489-111

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Targadox (NDC 69489-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Journey Medical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Targadox 50 mg 5ct

TARGADOX doxycycline hyclate USP tablets 50 mg oral dosage form label showing the product name, strength, dosage form, and quantity of 5 tablets. The label includes storage instructions, a barcode, distributor information for Journey Medical Corporation, Scottsdale, AZ, and notes that it is a professional sample not for sale.*

FDA Label Image

Targadox 50 mg 60ct

Label for TARGADOX (doxycycline hyclate USP) tablets 50 mg by Journey Medical Corporation. The label includes storage instructions, dosage reference, NDC 69489-111-60, and states the container holds 60 tablets. It specifies that each tablet contains doxycycline hyclate equivalent to 50 mg doxycycline and that the product is for prescription use only.*

FDA Label Image

Image 01

Chemical structure of doxycycline hyclate, showing its molecular diagram with associated components including hydrochloride (HCl), ethanol (CH3CH2OH), and water (H2O) molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.